About
Oncology Treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (21)
View allTotal Trials
21
As Lead Sponsor
12
As Collaborator
9
Total Enrollment
4,124
By Phase
PHASE2: 12PHASE2/PHASE3: 1PHASE1: 3PHASE3: 5
By Status
NOT_YET_RECRUITING: 5RECRUITING: 5COMPLETED: 5UNKNOWN: 4SUSPENDED: 2
Clinical Trials Pipeline21 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT07044349Lead Sponsor
Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE2Not yet recruiting
72 participants
Started: Sep 30, 2025 · Completed: Mar 31, 2027
NCT06841679Lead Sponsor
Utidelone Capsule Combined with Capecitabine and Oxaliplatin in First-line Treatment of PD-L1-negative Gastric or Gastroesophageal Junction Adenocarcinoma Patients
PHASE2/PHASE3Not yet recruiting
778 participants
Started: May 1, 2025 · Completed: Sep 1, 2030
NCT06683703Lead Sponsor
Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases
PHASE2Not yet recruiting
118 participants
Started: Dec 1, 2024 · Completed: Dec 1, 2027
NCT06730581Lead Sponsor
Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors
PHASE2Not yet recruiting
100 participants
Started: Dec 1, 2024 · Completed: Dec 31, 2026
NCT06458413Collaborator
Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer
PHASE2Recruiting
40 participants
Started: Jun 5, 2024 · Completed: Dec 5, 2025
Locations (1)
Headquarters
Beijing, China
Map
Loading map...